Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

NCT02627053 is registered in ClinicalTrials.gov with Università degli Studi dell'Insubria as lead sponsor.

NCT NCT02627053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02627053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
Lead sponsor
Università degli Studi dell'Insubria
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2019
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mesenteric vein thrombosis, portal vein thrombosis, splenic vein thrombosis